Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 13 years of tradition, previously Swiss Scandinavian Bio-Business Seminar. It is organized by the Nordic countries in cooperation with Swiss partners.
By connecting healthcare innovations, investors and industry, Swiss Nordic Bio is the perfect opportunity to tap into the Swiss-Nordic life science scene. The event is offering an opportunity for 400 one-on-one meetings. Interested participants are invited to book a meeting between 8 Jan – 4 Feb 2019. Companies will also have the chance to pitch before the audience.
The conference has a broad focus within biotech and pharma (drug development, drug delivery, biomaterials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early-stage companies as well as global, commercial corporations.
Registration for the event closes on 4 February.